Kozak & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $924K | Buy |
4,849
+3,015
| +164% | +$575K | 0.19% | 26 |
|
|
2025
Q1 | $328K | Buy |
1,834
+113
| +7% | +$20.2K | 0.08% | 52 |
|
|
2024
Q4 | $312K | Buy |
1,721
+39
| +2% | +$7.07K | 0.07% | 55 |
|
|
2024
Q3 | $320K | Buy |
1,682
+211
| +14% | +$40.2K | 0.08% | 60 |
|
|
2024
Q2 | $241K | Hold |
1,471
| – | – | 0.06% | 70 |
|
|
2024
Q1 | $242K | Sell |
1,471
-42
| -3% | -$6.9K | 0.07% | 72 |
|
|
2023
Q4 | $244K | Sell |
1,513
-186
| -11% | -$30K | 0.08% | 69 |
|
|
2023
Q3 | $252K | Buy |
1,699
+10
| +0.6% | +$1.48K | 0.09% | 70 |
|
|
2023
Q2 | $228K | Sell |
1,689
-63
| -4% | -$8.51K | 0.09% | 77 |
|
|
2023
Q1 | $279K | Buy |
1,752
+11
| +0.6% | +$1.75K | 0.13% | 74 |
|
|
2022
Q4 | $281K | Buy |
1,741
+10
| +0.6% | +$1.61K | 0.14% | 67 |
|
|
2022
Q3 | $245K | Buy |
1,731
+11
| +0.6% | +$1.56K | 0.15% | 67 |
|
|
2022
Q2 | $263K | Buy |
1,720
+10
| +0.6% | +$1.53K | 0.18% | 58 |
|
|
2022
Q1 | $255K | Hold |
1,710
| – | – | 0.16% | 65 |
|
|
2021
Q4 | $255K | Buy |
1,710
+23
| +1% | +$3.43K | 0.16% | 65 |
|
|
2021
Q3 | $197K | Buy |
+1,687
| New | +$197K | 0.12% | 79 |
|